World Wires · story 38920 · corroborated · 1 source(s)

Lower dose of new pulmonary fibrosis drug shows promising results

Bristol Myers Squibb announced trial results showing a lower dose of admilparant successfully slowed pulmonary fibrosis progression.

Open in the desk

Coverage

What this site indexes